Park Ha Biological Technology Co., Ltd.
Data quality: 100%
BYAH
Nasdaq
Manufacturing
Chemicals
$1.04
▼
$0.01
(-0.95%)
Mkt Cap: 3.38 M
Price
$1.05
Mkt Cap
3.38 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Earnings declined -5191.25% over the past year
Generating 85,852.0 in free cash flow
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)6.00%
Earnings (1Y)-5191.25%
FCF Growth (3Y)N/A
Quality
Return on Equity
-885.84%
Below sector avg (-53.47%)
ROIC-677.76%
Net Margin-965.00%
Op. Margin-956.45%
Safety
Debt / Equity
N/A
Current Ratio3.68
Interest Coverage-588997.59
Valuation
PE (TTM)
-0.14
Above sector avg (-1.48)
P/B Ratio0.80
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.1 | -1.5 |
| P/B | 0.8 | 1.6 |
| ROE % | -885.8 | -53.5 |
| Net Margin % | -965.0 | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2026 | — | 2.68 M | — |
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | -5191.25% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2.52 M | Net Income (TTM) | -24.36 M |
| ROE | -885.84% | ROA | -539.29% |
| Gross Margin | 94.36% | Operating Margin | -956.45% |
| Net Margin | -965.00% | Free Cash Flow (TTM) | 85,852.0 |
| ROIC | -677.76% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 3.68 |
| Interest Coverage | -588997.59 | Asset Turnover | 0.56 |
| Working Capital | 4.07 M | Tangible Book Value | 4.24 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.14 | Forward P/E | N/A |
| P/B Ratio | 0.80 | P/S Ratio | 1.34 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 2.54% | ||
| Market Cap | 3.38 M | Enterprise Value | 3.38 M |
| Per Share | |||
| EPS (Diluted TTM) | -41.38 | Revenue / Share | 0.78 |
| FCF / Share | 0.03 | OCF / Share | 0.03 |
| EPS CAGR (1Y) | -207000.00% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | -0.35% |
| SBC-Adj. FCF | -23.98 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | 2.52 M | 2.38 M |
| Net Income | -24.36 M | 478,561.0 |
| EPS (Diluted) | -41.38 | 0.02 |
| Gross Profit | 2.38 M | 2.19 M |
| Operating Income | -24.15 M | 793,714.0 |
| EBITDA | — | — |
| R&D Expenses | 238,184.0 | 36,714.0 |
| SG&A Expenses | — | — |
| D&A | 109,369.0 | 22,686.0 |
| Interest Expense | 41.0 | 194.0 |
| Income Tax | 280,646.0 | 314,860.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 5.95 M | 3.08 M |
| Total Liabilities | 1.96 M | 1.58 M |
| Shareholders' Equity | 3.99 M | 1.51 M |
| Total Debt | — | — |
| Cash & Equivalents | 3.79 M | 547,498.0 |
| Current Assets | 5.50 M | 2.84 M |
| Current Liabilities | 1.88 M | 1.52 M |
{"event":"ticker_viewed","properties":{"ticker":"BYAH","listing_kind":"stock","pathname":"/stocks/byah","exchange":"Nasdaq","country":"US"}}